NCT01613456已完成不适用
Effect of S.Cerevisiae vs Placebo on the Improvement of Gastrointestinal Disorders,Especially During Irritable Bowel Syndrome. Randomized, Double-blind Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 364
- 试验地点
- 2
- 主要终点
- Change from baseline in discomfort score,obtained by Daily Likert Scale averaged by week
研究概览
简要总结
The main purpose of this study is the effect of the probiotic yeast Saccharomyces cerevisiae CNCM I-3856 on abdominal pain or intestinal discomfort in patients presenting with the irritable bowel syndrome (IBS)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change from baseline in discomfort score,obtained by Daily Likert Scale averaged by week
时间窗: baseline and week 8
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
Effect of Saccharomyces Cerevisiae on Vulvo-vaginal CandidiasisCandidiasis, VulvovaginalNCT02859493Lesaffre International80
终止
不适用
Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal CandidiasisVulvo-vaginal CandidiasisNCT02345096Lesaffre International22
已完成
1 期
Saccharomyces Cerevisiae for Irritable Bowel SyndromeIrritable Bowel SyndromeNCT05149599Ziauddin University30
进行中（未招募）
1 期
Effects of the probiotic Saccharomyces boulardii CNCM I-745 and the antibiotic Amoxicillin on the gut microbiota of healthy volunteers An open-label, randomized, parallel groups, monocentric studyEUCTR2016-003654-33-DEBIOCODEX48
已完成
早期 1 期
Saccharomyces Boulardii CNCM I-745 on Intestinal Barrier FunctionHealthyNCT05538247Mayo Clinic56